ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 173 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $640,000 | +23.6% | 8,563 | -6.1% | 0.02% | +23.5% |
| Q3 2021 | $518,000 | +43.5% | 9,116 | +11.1% | 0.02% | +41.7% |
| Q2 2021 | $361,000 | -12.4% | 8,203 | -1.8% | 0.01% | -20.0% |
| Q1 2021 | $412,000 | +140.9% | 8,350 | +105.1% | 0.02% | +150.0% |
| Q4 2020 | $171,000 | +2.4% | 4,072 | +11.5% | 0.01% | -14.3% |
| Q3 2020 | $167,000 | -3.5% | 3,652 | +5.8% | 0.01% | -12.5% |
| Q2 2020 | $173,000 | -8.9% | 3,452 | -6.5% | 0.01% | -11.1% |
| Q1 2020 | $190,000 | -89.7% | 3,691 | -85.8% | 0.01% | -82.4% |
| Q4 2018 | $1,840,000 | -23.4% | 25,973 | -7.6% | 0.05% | -34.6% |
| Q3 2018 | $2,401,000 | -23.4% | 28,096 | +3.9% | 0.08% | -18.8% |
| Q2 2018 | $3,133,000 | +59.8% | 27,035 | +11.6% | 0.10% | +52.4% |
| Q1 2018 | $1,961,000 | – | 24,233 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 1,055,719 | $35,367,000 | 12.68% |
| GREAT POINT PARTNERS LLC | 828,253 | $27,746,000 | 5.70% |
| McClain Value Management LLC | 116,153 | $3,891,000 | 4.80% |
| Stonepine Capital Management, LLC | 231,913 | $7,769,000 | 4.63% |
| ARMISTICE CAPITAL, LLC | 228,000 | $7,638,000 | 1.81% |
| Opaleye Management Inc. | 90,000 | $3,015,000 | 1.78% |
| Matarin Capital Management, LLC | 257,268 | $8,618,478,000 | 0.97% |
| HAYS ADVISORY LLC | 116,939 | $3,917,000 | 0.87% |
| Granahan Investment Management | 496,025 | $16,617,000 | 0.57% |
| AlphaMark Advisors, LLC | 33,000 | $1,106,000 | 0.57% |